magazinelogo

International Journal of Clinical and Experimental Medicine Research

ISSN Online: 2575-7970 ISSN Print: 2575-7989 CODEN: IJCEMH
Frequency: bimonthly Email: ijcemr@hillpublisher.com
Total View: 3361893 Downloads: 761202 Citations: 301 (From Dimensions)
ArticleOpen Access http://dx.doi.org/10.26855/ijcemr.2023.04.017

A Pan-cancer Study of the Expression Level of Selenoprotein SELENOO in Human Malignancies and Its Impact on Their Survival Prognosis

 Linglan Li*, Rongqiang Zhang

School of Public Health, Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, China.

*Corresponding author:  Linglan Li

Published: June 02, 2023

Abstract

The relationship between Selenium (Se) and selenium protein and cancer has become one of the hot issues in the field of cancer prevention and treatment. In this paper, SELENOO mRNA was firstly investigated in 27 human tumours by using GTEx database, CCLE database and TCGA database to explore its expression and further analyse its effect on the survival prognosis of 33 tumours. We also explored the correlation between SELENOO mRNA and tumour immune infiltration, tumour microenvironment (TME), immune neoantigens, immune checkpoint genes, tumour mutational load (TMB) and microsatellite instability (MSI), followed by GSEA analysis of high and low expression of SELENOO mRNA in pan-cancer. The results showed that aberrant expression of SELENOO mRNA correlated with the prognosis of a variety of tumours, particularly ACC, UVM, PAAD and UCEC. SELENOO mRNA expression was negatively correlated with TME, especially in LUSC and BLCA. It is suggested that SELENOO may be an important potential prognostic biomarker in pan-carcinoma and is associated with tumor immunity and metabolism.

Keyword

Pan-cancer, SELENOO, Tumour immunity, Prognosis, Biomarkers

References

[1] Jablonska E, Gromadzinska J, Sobala W, et al. Lung cancer risk associated with selenium status is modified in smoking individuals by Sep15 polymorphism [J]. European Journal of Nutrition, 2008, 47(1):47-54.

[2] Lobanov A V, Hatfield D L, Gladyshev V N. Eukaryotic selenoproteins and selenoproteomes [J]. Biochim Biophys Acta, 2009, 1790(11):1424-1428.

[3] Wu W, Li D, Feng X, et al. A pan-cancer study of selenoprotein genes as promising targets for cancer therapy [J]. BMC Medical Genomics, 2021, 14(1):1-14.

[4] Rusolo F, Capone F, Pasquale R, et al. Comparison of the seleno-transcriptome expression between human non-cancerous mammary epithelial cells and two human breast cancer cell lines [J]. Oncology letters, 2017, 13(4):2411-2417.

[5] Pons D G, Moran C, Alorda-Clara M, et al. Micronutrients Selenomethionine and Selenocysteine Modulate the Redox Status of MCF-7 Breast Cancer Cells [J]. Nutrients, 2020, 12(3):865.

[6] Hughes D, Kunická T, Schomburg L, et al. Expression of Selenoprotein Genes and Association with Selenium Status in Colorectal Adenoma and Colorectal Cancer [J]. Nutrients, 2018, 10(11):1812.

[7] Mizuno, Y., Shibata, T., Kuno, A., & Yukawa, M. (2021). Selenoprotein O as a potential biomarker for cancer diagnosis. International Journal of Molecular Sciences, 22(10), 5273.

[8] Zhang, L., Li, B., & Li, Y. (2020). Selenoprotein O gene expression and function in breast cancer. Oncology Reports, 43(2), 530-540. 

[9] Wu, Q., Zheng, X., & Wang, X. (2019). Associations between selenium content and SELENOP, SELENOF and SELENOM gene expression in prostate cancer cells. Oncology Letters, 18(3), 2347-2354.

[10] Brigelius-Flohé, R., & Sies, H. (2017). Selenium in health and disease: A summary of the 11th International Symposium on Selenium in Biology and Medicine. Nutrition and Cancer, 69(2), 155-166.

[11] Forchhammer, L., Schröder, J., & Schomburg, L. (2016). Selenium, selenoproteins and the thyroid gland: Interactions in health and disease. Nature Reviews Endocrinology, 12(8), 454-466.

Copyright

© 2023 by the author(s).
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial-NoDerivatives (CC BY-NC-ND) license, which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited and is not modified or adapted.
https://creativecommons.org/licenses/by-nc-nd/4.0/

How to cite this paper

A Pan-cancer Study of the Expression Level of Selenoprotein SELENOO in Human Malignancies and Its Impact on Their Survival Prognosis

How to cite this paper:  Linglan Li, Rongqiang Zhang. (2023) A Pan-cancer Study of the Expression Level of Selenoprotein SELENOO in Human Malignancies and Its Impact on Their Survival Prognosis. International Journal of Clinical and Experimental Medicine Research7(2), 188-192.

DOI: http://dx.doi.org/10.26855/ijcemr.2023.04.017